We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+4.14%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$100M
AUM Growth
-$34.3M
Cap. Flow
-$33.3M
Cap. Flow %
-33.2%
Top 10 Hldgs %
26.12%
Holding
294
New
64
Increased
32
Reduced
107
Closed
85

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$5.08M
2
UNH icon
UnitedHealth
UNH
+$4.05M
3
JNJ icon
Johnson & Johnson
JNJ
+$2.82M
4
NVO
Novo Nordisk
NVO
+$2.52M
5
ABBV icon
AbbVie
ABBV
+$2.39M

Sector Composition

Rank Sector Weight
1 Healthcare 54.58%
2 Real Estate 7.4%
3 Industrials 5.96%
4 Financials 5.87%
5 Technology 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORKA
151
Oruka Therapeutics
ORKA
$5.53B
$119K 0.12%
+6,140
New +$150K
EZA icon
152
iShares MSCI South Africa ETF
EZA
$530M
$118K 0.12%
2,818
+167
+6% +$8.02K
EWG icon
153
iShares MSCI Germany ETF
EWG
$1.5B
$117K 0.12%
3,684
+293
+9% +$9.52K
URI icon
154
United Rentals
URI
$63.4B
$112K 0.11%
159
-8
-5% -$6.5K
FLRN icon
155
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.11B
$107K 0.11%
3,485
+240
+7% +$7.38K
IGSB icon
156
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.9B
$106K 0.11%
2,057
+148
+8% +$7.69K
MUB icon
157
iShares National Muni Bond ETF
MUB
$45.5B
$105K 0.11%
988
+61
+7% +$6.55K
SCHP icon
158
Schwab US TIPS ETF
SCHP
$16.4B
$105K 0.1%
4,060
+290
+8% +$7.62K
LQD icon
159
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$35B
$104K 0.1%
971
+73
+8% +$7.99K
THD icon
160
iShares MSCI Thailand ETF
THD
$361M
$103K 0.1%
1,707
-316
-16% -$20.4K
MET icon
161
MetLife
MET
$59.8B
$101K 0.1%
1,237
-60
-5% -$4.99K
GM icon
162
General Motors
GM
$68.3B
$99.8K 0.1%
1,873
-99
-5% -$5.18K
WRB icon
163
W.R. Berkley
WRB
$27.1B
$93.7K 0.09%
1,601
-87
-5% -$5.21K
HCA icon
164
HCA Healthcare
HCA
$82.2B
$91.2K 0.09%
304
-17
-5% -$5.94K
FIX icon
165
Comfort Systems
FIX
$60.3B
$90.7K 0.09%
214
-37
-15% -$16.2K
CB icon
166
Chubb
CB
$137B
$88.7K 0.09%
321
-17
-5% -$4.83K
KKR icon
167
KKR & Co
KKR
$87.1B
$86.7K 0.09%
586
-102
-15% -$15K
AIG icon
168
American International
AIG
$42.3B
$82.7K 0.08%
1,136
-57
-5% -$4.29K
FCNCA icon
169
First Citizens BancShares
FCNCA
$24.1B
$82.4K 0.08%
39
-7
-15% -$14.7K
UHS icon
170
Universal Health Services
UHS
$9.12B
$81.6K 0.08%
455
-26
-5% -$5.29K
BURL icon
171
Burlington
BURL
$22.2B
$80.1K 0.08%
281
-49
-15% -$13.2K
EME icon
172
Emcor
EME
$33.1B
$78.1K 0.08%
172
-30
-15% -$14.2K
ALL icon
173
Allstate
ALL
$65.3B
$77.5K 0.08%
402
-69
-15% -$13.4K
LEN icon
174
Lennar Class A
LEN
$20B
$76K 0.08%
575
-31
-5% -$5.04K
F icon
175
Ford
F
$55.7B
$75.1K 0.07%
7,585
-315
-4% -$3.36K

Similar funds

AlphaCentric Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, AlphaCentric Advisors held 294 positions worth $100M, down 25% from $135M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

AlphaCentric Advisors withdrew a net $33.3M in Q4 2024, closing 85 positions and reducing 107 holdings. Its most notable exit was Rithm Capital, an estimated $4.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 58% a quarter earlier, followed by Real Estate and Industrials.

Against the trend, AlphaCentric Advisors opened a new position in Eli Lilly worth $4.74M.

  • AlphaCentric Advisors's largest Q4 2024 buy was Eli Lilly: 6,140 shares worth $4.74M.
  • AlphaCentric Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.03M increase.
  • AlphaCentric Advisors's biggest Q4 2024 reduction was Neurocrine Biosciences, cutting an estimated $2.33M.
  • AlphaCentric Advisors fully exited Rithm Capital in Q4 2024, selling an estimated $4.32M.
  • AlphaCentric Advisors's ten largest holdings make up 26% of its $100M portfolio in Q4 2024.
  • AlphaCentric Advisors opened 64 new positions and closed 85 in Q4 2024.
  • AlphaCentric Advisors's portfolio value fell 25% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.